European Pharmaceutical Review
NOVEMBER 29, 2023
This step is important as these countries are key markets for pharmaceuticals manufacturing. GSK propels its progress to Net Zero Renewable energy in the pharma supply chain The SMI Health Systems Task Force is a public-private partnership launched at COP26.
Medico Reach
FEBRUARY 8, 2023
The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 billion during 2020-2024. Are you intrigued to know what technologies will rule the pharma market and how they can benefit your business in 2023?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
NOVEMBER 14, 2023
This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. retail pharmacies to access a 30-day supply of Lantus for only $35. “We References: 1.
pharmaphorum
DECEMBER 16, 2022
The negotiations over the treaty are being hosted through the World Health Organization (WHO), with plans to officially adopt a binding agreement sealed by the United Nations health agency’s member countries in May 2024. The discussions over the treaty are set to continue for some time.
European Pharmaceutical Review
JULY 21, 2023
Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Recommendations were also published earlier this year for all stakeholders in the pharma supply chain.
pharmaphorum
NOVEMBER 25, 2022
The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting.
European Pharmaceutical Review
DECEMBER 18, 2023
In 2023, the pharma industry has] witnessed tremendous advances in CAR T-cell immunotherapy of solid tumours” Another treatment modality that has witnessed significant advancement this year in the pharmaceutical industry, is cell and gene therapy. and subsequently enter into force in Denmark in July 2024.
Expert insights. Personalized for you.
81 
Let's personalize your content